Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer - A retrospective review of Chinese patients and comparison with an historic Western series

Radiotherapy and Oncology

Volumn 62, Issue 2, 2002, Pages 185-189

  Ma, Brigette ^a   Yeo, Winnie ^a   Hui, Pun ^a   Ho, Wing M ^a   Johnson, Philip J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Acute toxicity; Adjuvant chemotherapy; Breast cancer; Chinese; Cyclophosphamide; Doxorubicin

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; METOCLOPRAMIDE; SEROTONIN;

ACUTE TOXICITY; ALOPECIA; ALTERNATIVE MEDICINE; ARTICLE; BODY FAT; BONE MARROW TOXICITY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INCIDENCE; CARDIOTOXICITY; CAUCASIAN; CHINESE; COMPARATIVE STUDY; FEVER; HEPATITIS B; HUMAN; LIVER TOXICITY; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; VOMITING;

ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; CYCLOPHOSPHAMIDE; DIARRHEA; DOXORUBICIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS, TOXIC; HUMANS; NEUTROPENIA; RETROSPECTIVE STUDIES;

EID: 0036221452     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00003-8     Document Type: Article

References (20)

1. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma
2. Response to treatment of breast cancer
3. A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer
4. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore
5. Polychemotherapy for early breast cancer: An overview of the randomized trials
6. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with six months of cyclophosphamide, methotrexate and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: Result from the National Surgical Adjuvant Breast and Bowel Project B-15
7. Actual versus ideal weight in the calculation of surface area effects on the dose of 11 chemotherapy agents
8. Acute toxicity during adjuvant chemotherapy for breast cancer: The National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents
9. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese
10. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at MD Anderson Hospital and Tumor Institute
11. Influence of race or ethnicity on pharmacokinetics of drugs
12. Hepatitis B infection in patients with lymphomas
13. Hepatitis B virus infection in Chinese families in Hong Kong
14. Quality of adjuvant chemotherapy in primary breast cancer in a non-trial setting. A comprehensive cancer centre study
15. Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area
16. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: Results from cancer and leukemia group B study 8541
17. Asians have lower body mass index (BMI) but higher percent body fat than do whites: Comparisons of anthropometric measurements
18. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy
19. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors